- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Eduardo Schur
Articles
Commercial Models for the Changing Life Sciences Market
Life sciences companies have an opportunity to craft a sales approach that resonates with clients, protects against future disruptions and stands out from the competition.
New Standards for First-to-Launch Players
While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.
Research Reveals New Launch Standards for First-to-Launch Pharma and Biotech Companies in the U.S.
While COVID-19 has shifted the rules of the healthcare industry, research shows there was already progress on changes being made for how pharma companies are launching products.
505(b)(2): A Pathway to Competitiveness Through Innovation for Specialty and Generic Companies
As the market for specialty and generic products continues to become more competitive and pricing pressures increase, the 505(b)(2) pathway may allow companies more options to diversify their portfolios.